SCHEMBL24534286

SCHEMBL24534286

CC(C)(C)NC(=S)Nc1ccc(NC(=S)C(C)(C)C)cc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.68
ALDH1A1 P00352 4/20 0.64
MEN1 O00255 4/20 0.64
KMT2A Q03164 4/20 0.64
GAA P10253 3/20 0.64
L3MBTL1 Q9Y468 3/20 0.64
CYP3A4 P08684 3/20 0.64
SMN1; SMN2 Q16637 2/20 0.64
ALOX12 P18054 2/20 0.64
MAPT P10636 2/20 0.64
CYP1A2 P05177 2/20 0.64
CYP2C19 P33261 2/20 0.64
CYP2D6 P10635 1/20 0.64
CYP2C9 P11712 1/20 0.64
HPGD P15428 1/20 0.64
NPSR1 Q6W5P4 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
LMNA P02545 1/20 0.44
POLB P06746 1/20 0.42
KDM4E B2RXH2 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19891039 0.81 HTT (0.68) HTTALDH1A1MEN1KMT2AGAA
SCHEMBL17465537 0.81 HTT (0.68) HTTALDH1A1MEN1KMT2AGAA
SCHEMBL3067730 0.80 GAA (0.86) HTTALDH1A1MEN1KMT2AGAA
SCHEMBL8612093 0.79 HTT (0.66) HTTALDH1A1MEN1KMT2AGAA
SCHEMBL25507531 0.78 HTT (0.64) HTTALDH1A1MEN1KMT2AGAA
SCHEMBL25494263 0.78 HTT (0.64) HTTALDH1A1MEN1KMT2AGAA
SCHEMBL25474912 0.78 TDP1 (0.56) HTTALDH1A1MEN1KMT2AGAA
SCHEMBL6068080 0.77 HTT (0.62) HTTALDH1A1MEN1KMT2AGAA
SCHEMBL12347759 0.76 LMNA (0.59) HTTALDH1A1MEN1KMT2AGAA
SCHEMBL14447512 0.75 TAS2R38 (0.58) ALDH1A1MEN1KMT2AGAAL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11571481-B2 Peptide-linked drug delivery system CORNELL UNIVERSITY (US) 2023-02-07 US disclosed
US-20220193248-A1 PEPTIDE-LINKED DRUG DELIVERY SYSTEM CORNELL UNIVERSITY 2022-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220193248-A1 PEPTIDE-LINKED DRUG DELIVERY SYSTEM GLS, AGBL2, ATP6V1B1 HTT 1255/4885ALDH1A1 3364/4885MEN1 2191/4885
US-11571481-B2 Peptide-linked drug delivery system GLS, AGBL2, ATP6V1B1 HTT 1255/4885ALDH1A1 3364/4885MEN1 2191/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.